Organization | Sao Jose do Rio Preto University

Sao Jose do Rio Preto University Report issue

Academic/Hospital Phase 3 Phase 4

Founded: São José do Rio Preto Brazil (2009)

Organization Overview

First Clinical Trial

2009

NCT00655408

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 4 Trials (5)

amiloride (midamor) (1 trial)

bisoprolol (zebeta) (1 trial)

furosemide (lasix) (1 trial)

ramipril (altace) (1 trial)

spironolactone (aldactone) (1 trial)

Drugs in Phase 3 Trials (3)

beriplast p (1 trial)

tissucol (1 trial)

tranilast (1 trial)

Drugs in Other Trials (2)

ferrous sulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Coronary Vasospasm (Phase 4)

Hypertension (Phase 4)

Pterygium (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 10